2024 Fellowship Recipients

Award Amount: $200,000 (two-year)

Recipient: Elisa Bergaggio, PhD

Institution: Boston Children’s Hospital

Project Title: “Enhancing ALK.CAR-T efficacy in solid tumors”

Award Amount: $200,000 (two-year)

Recipient: Arielle Elkrief, MD

Institution: University of Montreal

Project Title: “Identification of the next generation of microbiome therapeutics in combination with immune checkpoint blockade to improve outcomes for patients with melanoma”

Award Amount: $100,000 (one-year)

Recipient: Benjamin R. Schrank, MD, PhD

Institution: The University of Texas MD Anderson Cancer Center

Project Title: “Enhancing Tumor-Immune Interactions in Breast Cancer via an Immunostimulatory Antibody-Drug Conjugate

Award Amount: $100,000 (one-year)

Recipient: Victor Arrieta, MD, PhD

Institution: Northwestern University

Project Title: “Leveraging DNA Methylation Signatures to Decode Clinical Responses to Immune Checkpoint Blockade in Glioblastoma”

Award Amount: $40,000 (one-year)

Recipient: Gabriele Casirati, MD, PhD

Institution: Dana-Farber Cancer Institute

Project Title: “Epitope edited Hematopoietic Stem Cells to Eliminate On-target/Off-tumor Toxicity”

This year’s SITC Forward Fund Fellowships were made possible through the generosity of Bristol Myers Squibb, Mallinckrodt Pharmaceuticals, Melanoma Research Alliance and Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc.

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014